Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

The Safety, Immune Persistence and Consistency of Inactivated Enterovirus 71 Vaccine (Human Diploid Cell, KMB-17)

NCT02999828 is registered in ClinicalTrials.gov with Chinese Academy of Medical Sciences as lead sponsor.

NCT NCT02999828
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02999828 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
The Safety, Immune Persistence and Consistency of Inactivated Enterovirus 71 Vaccine (Human Diploid Cell, KMB-17)
Lead sponsor
Chinese Academy of Medical Sciences
Phase
Phase 4
Overall status
Unknown status
Start date
September 30, 2016
Completion date
February 28, 2019
Enrollment
20,770 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

immunization of inactivated ev71 vaccine, safety of inactivated ev71 vaccine